Motomiya, Y., Kaneko, Y., Motomiya, Y., & Higashimoto, Y. (2024). Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor. Journal of Clinical Nephrology, 8(3), 132–137. https://doi.org/10.29328/journal.jcn.1001141